DE69004817D1 - Zusammensetzung und Verfahren zur Behandlung von Erkrankungen. - Google Patents
Zusammensetzung und Verfahren zur Behandlung von Erkrankungen.Info
- Publication number
- DE69004817D1 DE69004817D1 DE90300855T DE69004817T DE69004817D1 DE 69004817 D1 DE69004817 D1 DE 69004817D1 DE 90300855 T DE90300855 T DE 90300855T DE 69004817 T DE69004817 T DE 69004817T DE 69004817 D1 DE69004817 D1 DE 69004817D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- diseases
- treatment
- composition
- arylpropionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/302,210 US5032384A (en) | 1989-01-27 | 1989-01-27 | Compositions and method for the treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69004817D1 true DE69004817D1 (de) | 1994-01-13 |
| DE69004817T2 DE69004817T2 (de) | 1994-04-14 |
Family
ID=23166770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE90300855T Expired - Lifetime DE69004817T2 (de) | 1989-01-27 | 1990-01-26 | Zusammensetzung und Verfahren zur Behandlung von Erkrankungen. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5032384A (de) |
| EP (1) | EP0380367B1 (de) |
| JP (1) | JP2764451B2 (de) |
| AT (1) | ATE97805T1 (de) |
| AU (1) | AU622756B2 (de) |
| CA (1) | CA2008739C (de) |
| DE (1) | DE69004817T2 (de) |
| DK (1) | DK0380367T3 (de) |
| ES (1) | ES2060014T3 (de) |
| NZ (1) | NZ232250A (de) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5032384A (en) * | 1989-01-27 | 1991-07-16 | Block Drug Company, Inc. | Compositions and method for the treatment of disease |
| US5188817A (en) * | 1989-03-27 | 1993-02-23 | Julius Ozick | Method of treatment for periodontitis |
| JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5464609A (en) * | 1990-03-16 | 1995-11-07 | The Procter & Gamble Company | Use of ketorolac for treatment of oral diseases and conditions |
| DE69119588T2 (de) * | 1990-03-16 | 1996-11-21 | Procter & Gamble | Verwendung von ketorolac zur behandlung von periodontitis |
| CA2061477A1 (en) * | 1991-03-25 | 1992-09-26 | Lawrence J. Daher | Analgesic composition containing beta-carotene |
| US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
| EP0648113A4 (de) * | 1992-04-23 | 1996-12-04 | Berlex Lab | Bioadhaesive feste mineraloelemulsion. |
| US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| FR2698788B1 (fr) * | 1992-12-09 | 1995-03-03 | Union Pharma Scient Appl | Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation. |
| AU6582194A (en) * | 1993-04-27 | 1994-11-21 | Sunstar Inc. | Intraoral composition |
| FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
| US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| US5462728A (en) * | 1994-04-05 | 1995-10-31 | Blank; Izhak | Pharmaceutical compositions |
| JP2742333B2 (ja) * | 1994-05-06 | 1998-04-22 | アルコン ラボラトリーズ，インコーポレイテッド | 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用 |
| US5811453A (en) | 1994-12-23 | 1998-09-22 | Alcon Laboratories, Inc. | Viscoelastic compositions and methods of use |
| US5643943A (en) * | 1994-12-23 | 1997-07-01 | Alcon Laboratories, Inc. | Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis |
| US5607966A (en) * | 1994-12-23 | 1997-03-04 | Alcon Laboratories, Inc. | Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs |
| AU706541B2 (en) | 1995-06-09 | 1999-06-17 | Euro-Celtique S.A. | Formulations and methods for providing prolonged local anesthesia |
| FR2742054B1 (fr) * | 1995-12-06 | 1998-01-09 | Synthelabo | Compositions pharmaceutiques contenant un agent anti-inflammatoire et des ceramides vegetales |
| AU733867B2 (en) | 1996-06-24 | 2001-05-31 | Euro-Celtique S.A. | Methods for providing safe local anesthesia |
| US6046187A (en) * | 1996-09-16 | 2000-04-04 | Children's Medical Center Corporation | Formulations and methods for providing prolonged local anesthesia |
| US5827886A (en) * | 1997-05-07 | 1998-10-27 | Thione International, Inc. | Composition for relief of arthritis-induced symptoms |
| AU739384B2 (en) * | 1997-07-02 | 2001-10-11 | Euro-Celtique S.A. | Prolonged anesthesia in joints and body spaces |
| US6138683A (en) * | 1997-09-19 | 2000-10-31 | Thione International, Inc. | Smokeless tobacco products containing antioxidants |
| US5922346A (en) * | 1997-12-01 | 1999-07-13 | Thione International, Inc. | Antioxidant preparation |
| US6228347B1 (en) * | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
| JP3763075B2 (ja) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
| ITMI981586A1 (it) * | 1998-07-10 | 2000-01-10 | Giorgio Panin | Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose |
| FR2781156B1 (fr) * | 1998-07-20 | 2001-06-29 | Lafon Labor | Composition pharmaceutique destinee notamment a la prevention et au traitement des radiomucites et des chimiomucites |
| US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
| US6254891B1 (en) | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
| US6201028B1 (en) | 1998-12-08 | 2001-03-13 | The Rockefeller University | Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs |
| US6200550B1 (en) | 1998-12-11 | 2001-03-13 | Q-Pharma, Inc. | Oral care compositions comprising coenzyme Q10 |
| KR19990068298A (ko) * | 1999-03-12 | 1999-09-06 | 정명우 | 장미씨기름을함유하는치약조성물 |
| US7592304B2 (en) * | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US20030158111A1 (en) * | 1999-10-01 | 2003-08-21 | David Bar-Or | Methods and products for oral care |
| JP4886107B2 (ja) * | 2000-10-13 | 2012-02-29 | サンスター株式会社 | 歯周病予防用口腔内溶解錠 |
| JP2004521111A (ja) * | 2001-01-25 | 2004-07-15 | ユーロ−セルティーク，エス．エイ． | 局所麻酔薬および使用法 |
| JP4803889B2 (ja) * | 2001-03-01 | 2011-10-26 | 日本ゼトック株式会社 | 非水系練歯磨剤 |
| FR2832630B1 (fr) * | 2001-11-28 | 2005-01-14 | Oreal | Composition cosmetique et/ou dermatologique contenant au moins un actif hydrophile sensible a l'oxydation stabilise par au moins un copolymere de n-vinylimidazole |
| DE10163543A1 (de) * | 2001-12-21 | 2003-07-31 | Basf Ag | Tocopherol-haltige Superabsorber |
| DE10224612A1 (de) * | 2002-06-04 | 2003-12-24 | Lohmann Therapie Syst Lts | Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung |
| EP1374849B1 (de) * | 2002-06-20 | 2005-11-23 | L'oreal | Kosmetische und/oder dermatologische Verwendung einer Zusammensetzung, die mindestens einen oxidationsempfindlichen hydrophilen durch mindestens einem Polymer oder Copolymer stabilisierten Wirkstoff aus Maleinsäureanhydrid enthält |
| NZ538842A (en) * | 2002-09-28 | 2008-03-28 | Mcneil Ppc Inc | Immediate release dosage form comprising a solid core of density 0.9 g/ml surrounded by a shell that is readily soluble to gastrointestinal fluids |
| JP4495901B2 (ja) * | 2002-10-02 | 2010-07-07 | 日本澱粉工業株式会社 | 口腔用剤用活性阻害剤 |
| BR0315942A (pt) * | 2002-11-27 | 2005-10-04 | Dmi Biosciences Inc | Tratamento de doenças e condições mediadas pelo aumento de fosforilação |
| JP2006528690A (ja) * | 2003-05-07 | 2006-12-21 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | 口腔ケア方法および製品 |
| JP2007506767A (ja) * | 2003-09-25 | 2007-03-22 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | Ｎ−アシル−ｌ−アスパラギン酸を利用した方法および製造物 |
| KR100564934B1 (ko) * | 2003-12-09 | 2006-03-30 | 학교법인 건국대학교 | 녹차로부터 추출한 폴리페놀을 함유한 가식성 필름의 제조방법 |
| US8168161B2 (en) * | 2004-12-22 | 2012-05-01 | Hill's Pet Nutrition, Inc. | Method to promote oral health in companion animals |
| JP5242543B2 (ja) * | 2006-03-16 | 2013-07-24 | ノバルティス アーゲー | 味をマスキングした活性薬剤を含有する固体剤形 |
| JP2009269851A (ja) * | 2008-05-07 | 2009-11-19 | Nikko Chemical Co Ltd | プロスタグランジンｅ２産生抑制剤及びその利用 |
| US8905760B2 (en) * | 2008-11-04 | 2014-12-09 | Duane C. Keller | Methods and systems for progressively treating and controlling oral periopathogens causing systemic inflammations |
| US8956161B2 (en) * | 2008-11-04 | 2015-02-17 | Duane C Keller | Article and method for controlling oral-originated systemic disease |
| TWI435733B (zh) * | 2010-01-29 | 2014-05-01 | Colgate Palmolive Co | 用於口臭控制之口腔保健調配物 |
| US8591229B2 (en) | 2010-12-16 | 2013-11-26 | Duane C. Keller | Devices and methods for creating a positive pressure environment for treatment of oral biofilms associated with periodontal disease |
| RU2763874C1 (ru) * | 2021-05-04 | 2022-01-11 | Светлана Николаевна Саблина | Способ лечения воспалительных заболеваний пародонта у женщин в мено- и постменопаузальном периодах |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411885A (en) * | 1980-09-30 | 1983-10-25 | Barels Ronald R | Vitamin E oil based dentifrice |
| JPS57139013A (en) * | 1981-02-19 | 1982-08-27 | Eisai Co Ltd | Prophylactic or remedy for periodontosis |
| AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
| CH655656B (de) * | 1982-10-07 | 1986-05-15 | ||
| JPS59122422A (ja) * | 1982-12-29 | 1984-07-14 | Toko Yakuhin Kogyo Kk | 口腔用消炎鎮痛ゲル剤 |
| JPS59222406A (ja) * | 1983-06-01 | 1984-12-14 | Teijin Ltd | 歯周疾患治療用製剤及びその製造法 |
| US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
| DE3346525A1 (de) * | 1983-12-22 | 1985-07-04 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich |
| JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | ４−ビフエニリル酢酸系化合物含有脂肪乳剤 |
| EP0187703B1 (de) * | 1985-01-11 | 1992-08-05 | Teijin Limited | Präparate mit verzögerter Freisetzung |
| DE3665538D1 (en) * | 1985-01-23 | 1989-10-19 | Asta Pharma Ag | Synergistic combination of flupirtin and non-steroidal anti-phlogistics |
| GB8507058D0 (en) * | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
| EP0200508B1 (de) * | 1985-04-27 | 1991-10-02 | Nitto Denko Corporation | Klebepflaster und Arzneimittel für die Mundhöhle |
| EP0207638B1 (de) * | 1985-06-04 | 1990-12-19 | Teijin Limited | Arzneizubereitung mit verzögerter Wirkstoffabgabe |
| JPH0676314B2 (ja) * | 1985-09-30 | 1994-09-28 | 花王株式会社 | 坐剤基剤及び坐剤 |
| JPS62223115A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
| JPH0744940B2 (ja) * | 1986-12-24 | 1995-05-17 | ライオン株式会社 | 口腔貼付用基材 |
| EP0279867A3 (de) * | 1987-01-12 | 1988-10-05 | EFEKA Friedrich & Kaufmann GmbH & Co KG | Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen |
| US4869897A (en) * | 1987-10-22 | 1989-09-26 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid |
| US4946671A (en) * | 1987-10-22 | 1990-08-07 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
| US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
| US4954332A (en) * | 1987-10-22 | 1990-09-04 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
| US4847072A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate |
| US4847069A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
| US4939135A (en) * | 1988-10-03 | 1990-07-03 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
| US5032384A (en) * | 1989-01-27 | 1991-07-16 | Block Drug Company, Inc. | Compositions and method for the treatment of disease |
-
1989
- 1989-01-27 US US07/302,210 patent/US5032384A/en not_active Expired - Lifetime
-
1990
- 1990-01-24 AU AU48761/90A patent/AU622756B2/en not_active Expired
- 1990-01-25 NZ NZ232250A patent/NZ232250A/en unknown
- 1990-01-26 EP EP90300855A patent/EP0380367B1/de not_active Expired - Lifetime
- 1990-01-26 CA CA002008739A patent/CA2008739C/en not_active Expired - Lifetime
- 1990-01-26 DK DK90300855.5T patent/DK0380367T3/da active
- 1990-01-26 DE DE90300855T patent/DE69004817T2/de not_active Expired - Lifetime
- 1990-01-26 ES ES90300855T patent/ES2060014T3/es not_active Expired - Lifetime
- 1990-01-26 JP JP2017688A patent/JP2764451B2/ja not_active Expired - Lifetime
- 1990-01-26 AT AT90300855T patent/ATE97805T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE97805T1 (de) | 1993-12-15 |
| JP2764451B2 (ja) | 1998-06-11 |
| CA2008739A1 (en) | 1990-07-27 |
| NZ232250A (en) | 1991-04-26 |
| AU4876190A (en) | 1990-08-09 |
| AU622756B2 (en) | 1992-04-16 |
| CA2008739C (en) | 1998-06-23 |
| JPH02270815A (ja) | 1990-11-05 |
| ES2060014T3 (es) | 1994-11-16 |
| DK0380367T3 (da) | 1994-02-28 |
| US5032384A (en) | 1991-07-16 |
| DE69004817T2 (de) | 1994-04-14 |
| EP0380367B1 (de) | 1993-12-01 |
| EP0380367A1 (de) | 1990-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69004817D1 (de) | Zusammensetzung und Verfahren zur Behandlung von Erkrankungen. | |
| ATE73657T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| DE3881299D1 (de) | Retinoide zur behandlung lichtgeschaedigter haut. | |
| ATA162587A (de) | Verfahren zur herstellung von neuen benzolderivaten sowie von diese derivate enthaltenden pharmazeutischen zusammensetzungen und verfahren zur verringerung von entzündung bei tieren | |
| ATE101515T1 (de) | Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur behandlung der symptome der unenthaltsamkeit. | |
| ATE25245T1 (de) | Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel. | |
| DE59205846D1 (de) | Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems | |
| SE8902701D0 (sv) | Fettsyrakomposition | |
| FR2426461A1 (fr) | Acides gras, derives de ceux-ci et medicaments qui en contiennent | |
| ATE191143T1 (de) | Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck | |
| DE60026152D1 (de) | Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs | |
| DE3689117D1 (de) | Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung. | |
| DE69325393T2 (de) | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen | |
| DE69010162T2 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
| DE69029100T2 (de) | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris | |
| ATE268587T1 (de) | Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten | |
| ATE22532T1 (de) | Pharmazeutische zusammensetzung. | |
| DE59002748D1 (de) | Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen. | |
| ATE10841T1 (de) | Tricyclische thiazolyloxamidsaeuren und derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. | |
| ATE69949T1 (de) | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ATE22282T1 (de) | Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
| PT96814A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo acido trans-retinoico e acido azelaico | |
| ATE135702T1 (de) | Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen | |
| ATE271896T1 (de) | Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis | |
| ATE27272T1 (de) | 1-aroyl-5-oxo-2-pyrrolidinpropanoic-saeure und deren estern. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |